Kevin Hrusovsky

Selected news for the person - Kevin Hrusovsky, collected since 10/2017. Recent stories appear in baseballnewssource.com and financialbuzz.com. This person shares healthcare news with COVID-19, Digital Health, Infectious Disease and many others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
6/2/2021 Quanterix Chairman and CEO Kevin Hrusovsky to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference and Appear on the June 3 Episode of The Bio Report digitalmedianet.com Quanterix Chairman and CEO Kevin Hrusovsky to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference and Appear on the June 3 Episode of The Bio Report Posted on June 2, 2021BILLERICA, Mass.–(BUSINESS WIRE)– Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that Chairman and Chief Executive Officer, Quanterix, Kevin Hrusovsky will be delivering a ...
6/2/2021 Quanterix Chairman and CEO Kevin Hrusovsky to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference and Appear on the June 3 Episode of The Bio Report Yahoo News Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that Chairman and Chief Executive Officer, Quanterix, Kevin Hrusovsky will be delivering a virtual presentation at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10 th at 3:50pm ET.Attendees can access the public webcast at https://kvgo.com/gs-global-healthcare/quanterix-june-2021 or by visiting the News & Events ...
6/2/2021 Quanterix Chairman and CEO Kevin Hrusovsky to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference and Appear on the June 3 Episode of The Bio Report - Stocks News Feed stocksnewsfeed.com BILLERICA, Mass.–(BUSINESS WIRE)– Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that Chairman and Chief Executive Officer, Quanterix, Kevin Hrusovsky will be delivering a virtual presentation at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10 th at 3:50pm ET.Attendees can access the public webcast at https://kvgo.com/gs-global-healthcare/quanterix-june-2021 ...
6/2/2021 Quanterix Chairman and CEO Kevin Hrusovsky to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference and Appear on the June 3 Episode of The Bio Report | 2021-06-02 | Press Releases | Stockhouse stockhouse.com Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that Chairman and Chief Executive Officer, Quanterix, Kevin Hrusovsky will be delivering a virtual presentation at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10 th at 3:50pm ET.Attendees can access the public webcast at https://kvgo.com/gs-global-healthcare/quanterix-june-2021 or by visiting the News & Events ...
6/2/2021 Quanterix Chairman and CEO Kevin Hrusovsky to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference and Appear on the June 3 Episode of The Bio Report | Business Wire Business Wire BILLERICA, Mass.--( BUSINESS WIRE )-- Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that Chairman and Chief Executive Officer, Quanterix, Kevin Hrusovsky will be delivering a virtual presentation at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10 th at 3:50pm ET.Attendees can access the public webcast at https://kvgo.com/gs-global-healthcare/quanterix-june-2021 or by ...
6/2/2021 malvern-online.com Quanterix Corporation ( NASDAQ:QTRX ), a company digitizing biomarker analysis to advance the science of precision health, today announced that Chairman and Chief Executive Officer, Quanterix, Kevin Hrusovsky will be delivering a virtual presentation at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10 th at 3:50pm ET.Attendees can access the public webcast at https://kvgo.com/gs-global-healthcare/quanterix-june-2021 or by visiting the News & Events ...
6/2/2021 Quanterix Chairman and CEO Kevin Hrusovsky to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference and Appear on the June 3 Episode of The Bio Report | Financial Buzz financialbuzz.com Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that Chairman and Chief Executive Officer, Quanterix, Kevin Hrusovsky will be delivering a virtual presentation at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10 th at 3:50pm ET.Attendees can access the public webcast at https://kvgo.com/gs-global-healthcare/quanterix-june-2021 or by visiting the News & Events ...
4/23/2021 Quanterix Webinar: Recent Advancements in Neurodegenerative Biomarkers: Progress Towards A Diagnostic Blood Test for Alzheimers Disease financialbuzz.com ... help advance Alzheimer’s clinical trials and diagnostics.The webinar will take place on Friday, April 23, 2021 at 10:00am ET . The discussion will be led by Quanterix Chairman, Chief Executive Officer, and President, Kevin Hrusovsky and will feature Charlotte Teunissen, Ph.D., UMC Amsterdam, and Henrik Zetterberg. Ph.D., University of Gothenberg.To register for the webinar, visit https://www.quanterix.com/webinars/About QuanterixQuanterix is a company that’s digitizing biomarker ...
4/22/2021 Quanterix Webinar: Recent Advancements in Neurodegenerative Biomarkers: Progress Towards A Diagnostic Blood Test for Alzheimer's Disease Business Wire ... help advance Alzheimer’s clinical trials and diagnostics.The webinar will take place on Friday, April 23, 2021 at 10:00am ET . The discussion will be led by Quanterix Chairman, Chief Executive Officer, and President, Kevin Hrusovsky and will feature Charlotte Teunissen, Ph.D., UMC Amsterdam, and Henrik Zetterberg. Ph.D., University of Gothenberg.To register for the webinar, visit https://www.quanterix.com/webinars/About QuanterixQuanterix is a company that’s digitizing biomarker ...
4/22/2021 Quanterix Announces Appointment of Interim Chief Financial Officer cardiacvascularnews.com Google+BILLERICA, Mass.–( BUSINESS WIRE )– Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it has appointed Shawn Stetson as the Company’s interim chief financial officer, effective May 11, 2021. Mr. Stetson will assume his new responsibilities upon the departure of the Company’s current chief financial officer Amol Chaubal, who has accepted the ...
4/21/2021 Quanterix Announces Appointment of Interim Chief Financial Officer Business Wire BILLERICA, Mass.--( BUSINESS WIRE )-- Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it has appointed Shawn Stetson as the Company's interim chief financial officer, effective May 11, 2021. Mr. Stetson will assume his new responsibilities upon the departure of the Company’s current chief financial officer Amol Chaubal, who has accepted the chief financial officer role ...
4/21/2021 Quanterix Announces Appointment of Interim Chief Financial Officer Business Insider ... responsibilities upon the departure of the Company’s current chief financial officer Amol Chaubal, who has accepted the chief financial officer role at Waters Corporation. Quanterix has initiated a search for a permanent replacement. Kevin Hrusovsky , Chairman, Chief Executive Officer, and President of Quanterix commented, "With his strong background and knowledge of our Company, we have full confidence in Shawn’s ability to lead the Quanterix finance team while we ...
4/21/2021 malvern-online.com Quanterix Corporation ( NASDAQ: QTRX ), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it has appointed Shawn Stetson as the Company's interim chief financial officer, effective May 11, 2021. Mr. Stetson will assume his new responsibilities upon the departure of the Company’s current chief financial officer Amol Chaubal, who has accepted the chief financial officer role at Waters Corporation. Quanterix ...
4/21/2021 Quanterix Announces Appointment of Interim Chief Financial Officer | 2021-04-21 | Press Releases | Stockhouse stockhouse.com Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it has appointed Shawn Stetson as the Company's interim chief financial officer, effective May 11, 2021. Mr. Stetson will assume his new responsibilities upon the departure of the Company’s current chief financial officer Amol Chaubal, who has accepted the chief financial officer role at Waters Corporation ...
4/21/2021 Quanterix Announces Appointment of Interim Chief Financial Officer financialbuzz.com Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it has appointed Shawn Stetson as the Company’s interim chief financial officer, effective May 11, 2021. Mr. Stetson will assume his new responsibilities upon the departure of the Company’s current chief financial officer Amol Chaubal, who has accepted the chief financial officer role at Waters Corporation ...
4/13/2021 Powering Precision Health Founder Leads Conversation at Precision Medicine Leaders Summit on Altering Precision Health with Next-Generation Proteomics bollyinside.com ... independent, non-profit organization dedicated to bringing the world’s leading physicians, scientists, innovators, investors and patient advocates together to unveil their latest research on new biomarkers that are revolutionizing precision health. Founded by Kevin Hrusovsky , a widely acclaimed thought leader and visionary in life sciences and personalized medicine, Powering Precision Health is a movement that represents the intersection of new technological capabilities with the latest medical research. It’s ...
4/13/2021 Powering Precision Health Founder Leads Conversation at the Precision Medicine Leaders Summit on Disrupting Precision Health with Next-Generation Proteomics financialbuzz.com Powering Precision Health (PPH), the internationally acclaimed Summit focused on precision health and the latest in biomarker research, today announced that its Founder and Chairman, and CEO of Quanterix Kevin Hrusovsky , will lead a panel on Tuesday, April 13, 2021, at the Precision Medicine Leaders Summit’s (PMLS) virtual conference on Disrupting Precision Health with Next-Generation Proteomics.Fulfilling the true promise for precision health lies in the power of ...
4/12/2021 Powering Precision Health Founder Leads Conversation at the Precision Medicine Leaders Summit on Disrupting Precision Health with Next-Generation Proteomics Yahoo News Virtual Conference to be Held April 13, 2021Powering Precision Health (PPH), the internationally acclaimed Summit focused on precision health and the latest in biomarker research, today announced that its Founder and Chairman, and CEO of Quanterix Kevin Hrusovsky , will lead a panel on Tuesday, April 13, 2021, at the Precision Medicine Leaders Summit’s (PMLS) virtual conference on Disrupting Precision Health with Next-Generation Proteomics.Fulfilling the true promise ...
4/12/2021 Powering Precision Health Founder Leads Conversation at the Precision Medicine Leaders Summit on Disrupting Precision Health with Next-Generation Proteomics Business Wire BILLERICA, Mass.- Powering Precision Health (PPH), the internationally acclaimed Summit focused on precision health and the latest in biomarker research, today announced that its Founder and Chairman, and CEO of Quanterix Kevin Hrusovsky , will lead a panel on Tuesday, April 13, 2021, at the Precision Medicine Leaders Summit’s (PMLS) virtual conference on Disrupting Precision Health with Next-Generation Proteomics.Fulfilling the true promise for precision health lies in the ...
3/26/2021 Quanterix Simoa Technology Demonstrates Advancements in COVID-19 Research through Viral Antigen Measurements in Blood and Saliva Samples financialbuzz.com ... overcome critical challenges with the accuracy, cost and availability of diagnostic tests, and with access to research tools that could help to enable a highly tailored approach to COVID-19 patient care,” said Kevin Hrusovsky , Chairman, Chief Executive Officer and President, Quanterix and Founder, Powering Precision Health (PPH). “While vaccine deployment continues at an aggressive pace, COVID-19 testing and clinical research tools will remain a global priority in ...